Antioxidant sulforaphane and sensitizer trinitrobenzene sulfonate induce carboxylesterase-1 through a novel element transactivated by nuclear factor-E2 related factor-2 by Chen, Yi-Tzai et al.
University of Rhode Island
DigitalCommons@URI
Biomedical and Pharmaceutical Sciences Faculty
Publications Biomedical and Pharmaceutical Sciences
2012
Antioxidant sulforaphane and sensitizer
trinitrobenzene sulfonate induce carboxylesterase-1
through a novel element transactivated by nuclear
factor-E2 related factor-2
Yi-Tzai Chen
University of Rhode Island
Deshi Shi
University of Rhode Island
See next page for additional authors
Creative Commons License
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0
License.
Follow this and additional works at: https://digitalcommons.uri.edu/bps_facpubs
This is a pre-publication author manuscript of the final, published article.
This Article is brought to you for free and open access by the Biomedical and Pharmaceutical Sciences at DigitalCommons@URI. It has been accepted
for inclusion in Biomedical and Pharmaceutical Sciences Faculty Publications by an authorized administrator of DigitalCommons@URI. For more
information, please contact digitalcommons@etal.uri.edu.
Citation/Publisher Attribution
Chen, Y.-T., Shi, D., Yang, D.m & Yan, B. (2012). Antioxidant sulforaphane and sensitizer trinitrobenzene sulfonate induce
carboxylesterase-1 through a novel element transactivated by nuclear factor-E2 related factor-2. Biochemical Pharmacology, 84(6),
864-871. doi: 10.1016/j.bcp.2012.06.025
Available at: https://doi.org/10.1016/j.bcp.2012.06.025
Authors
Yi-Tzai Chen, Deshi Shi, Dongfang Yang, and Bingfang Yan
This article is available at DigitalCommons@URI: https://digitalcommons.uri.edu/bps_facpubs/138
Antioxidant Sulforaphane and Sensitizer Trinitrobenzene
Sulfonate Induce Carboxylesterase-1 Through a Novel Element
Transactivated by Nuclear Factor-E2 Related Factor-2
Yi-Tzai Chen, Deshi Shi, Dongfang Yang, and Bingfang Yan
Department of Biomedical Sciences, Center for Pharmacogenomics and Molecular Therapy,
University of Rhode Island, Kingston, RI 02881
Abstract
Carboxylesterase-1 (CES1), the most versatile human carboxylesterase, plays critical roles in drug
metabolism and lipid mobilization. This enzyme is highly induced by antioxidants and sensitizers
in various cell lines. These compounds are known to activate nuclear factor-E2 related factor-2
(Nrf2) by reacting to kelch-like ECH-associated protein-1 (Keap1). The aims of this study were to
determine whether antioxidant sulforaphane (SFN) and sensitizer trinitrobenzene sulfonate
(TNBS) target Keap1 similarly and whether they use the same element for CES1 induction. Cells
over-expressing Keap1 were treated with TNBS or SFN and the formation of disulfide bonds
among Keap1 molecules were determined. SFN promoted intramolecular disulfide formation
whereas TNBS promoted intermolecular disulfide formation of Keap1. Two elements, sensitizing/
antioxidant response element (S/ARE) and ARE4, were identified to support Nrf2 in the regulated
expression of CES1A1. Both elements were bound by Nrf2, however, the S/ARE element
supported, whereas the ARE4 element repressed Nrf2 transactivation. The repression required
higher amounts of Nrf2, suggesting that the transactivation through the S/ARE element dominates
the trans-repression through the ARE4 element under normal antioxidative condition. These
findings conclude that compounds, although triggering the Keap1-Nrf2 pathway, may differ in the
mode of reacting with Keap1. These findings also conclude that both positive and negative Nrf2
elements exist even within the same gene, and such opposing mechanisms provide fine-tuning in
transcriptional regulation by the Keap1-Nrf2 pathway. High levels of CES1 are linked to lipid
retention. Excessive induction of CES1 by antioxidants and sensitizers likely provides a
mechanism for potential detrimental effect on human health.
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1. Introduction
Carboxylesterases (CES, E.C.3.1.1.1) constitute a large class of enzymes that play important
roles in drug metabolism and lipid mobilization [1-4]. In the human genome, seven
carboxylesterase genes are identified [1]. However, only three are catalytically characterized
including CES1, CES2 and CES3 [5]. CES1 is encoded by two distinct genes: CES1A1 and
CES1A2 [1], but CES1A1 is normally expressed to a greater extent [6]. CES1 has a broad
tissue distribution with the highest level in the liver microsomes [7]. CES1 is the most
versatile human carboxylesterase and catalyzes hydrolytic, synthetic and transactivation
reactions. While all carboxylesterases play roles in drug metabolism, emerging evidence
links the sustained high-level expression of CES1 to the increased risk of developing
cardiovascular diseases, obesity and insulin resistance [8, 9].
Antioxidants and skin sensitizers are two types of compounds recently shown to induce
CES1 [10-13]. Some sensitizers induced CES1 by as much as 20-fold [11]. While the
precise mechanism on the sensitizer-induction of CES1 remains to be established, the
induction of this carboxylesterase by antioxidants, on the other hand, is mediated by Nrf2
(nuclear factor-E2 related factor-2) [14]. This transcription factor recognizes antioxidant
response element (ARE) and confers transactivation [15]. RNA interference against Nrf2
abolished CES1 induction by antioxidants [14]. However, a native promoter reporter
containing putative AREs was repressed by Nrf2 [14]. Majority of skin sensitizers, on the
other hand, are sulfhydryl reactive agents and shown to react with kelch-like ECH-
associated protein-1 (Keap1) [10, 13], an inhibitor of Nrf2. Interaction with Keap1 by
sensitizers leads to Nrf2 activation. The magnitude of the activation was correlated with
their sensitizing potency [10].
The present study was performed to test the hypothesis that both antioxidants and sensitizers
react to Keap1 similarly and causes transactivation of CES1A1 via a novel Nrf2 element. To
test this hypothesis, Keap1-transfected cells were treated with sensitizer trinitrobenzene
sulfonate (TNBS) or antioxidant DL-sulforaphane (SFN) and various molecular species of
Keap1 were determined. In contrary to the hypothesis, SFN promoted intramolecular
oxidation whereas TNBS promoted intermolecular oxidation of Keap1. To locate the
element supporting the transactivation, the regulatory sequence of the CES1A1 gene was
dissected and tested for the responsiveness to TNBS, SFN or Nrf2. Two elements were
identified and designated as S/ARE (sensitizing/antioxidant response element) and ARE4,
respectively. Interestingly, the S/ARE element supported Nrf2 transactivation whereas the
ARE4 repressed it although the S/ARE element was a more sensitive target of Nrf2.
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2. Materials and Methods
2.1. Chemicals and supplies
Hanks balanced salt solution, TNBS and William's medium E (WME) were purchased from
Sigma (St. Louis, MO). SFN was purchased from Alexis (San Diego, CA). Dulbecco's
Modified Eagles Medium (DMEM), high fidelity Platinum Taq DNA polymerase, insulin-
transferrin-selenium (ITS) G supplement were purchased from Invitrogen (Carlsbad, CA).
Dual-Luciferase Reporter Assay System was from Promega (Madison, WI). Fetal bovine
serum (FBS) was from HyClone laboratories (Logan, UT). The antibody against
glyceradehyde-3-phosphate dehydrogenase (GAPDH) was from Abcam (Cambridge, UK),
and the antibody against Nrf2 (C-20) was from Santa Cruz Biotechnology (Santa Cruz, CA).
The goat anti-rabbit IgG conjugated with horseradish peroxidase was from Pierce
(Rockford, IL). Plated human primary hepatocytes were obtained from the Liver Tissues
Procurement and Distribution System (University of Minnesota) or CellzDirect (Pittsboro,
NC). Human dermal fibroblasts (cryopreserved) were purchased from Cascade Biologics
(Portland, OR). Unless otherwise specified, all other reagents were purchased from Fisher
Scientific (Fair Lawn, NJ).
2.2. Reporter constructs and cotransfection assays
CES1A1 promoter reporters were prepared to contain various lengths of CES1A1 genomic
sequence. All promoter reporters were subcloned from the CES1A1-6560-Luc reporter. This
reporter was prepared by inserting the genomic fragment from -6560 to -21 (relatively to the
translation initiation codon) into the pGL3 basic vector through Mlu I and Xho I sites. All
cloning and subcloning were performed by PCR with high fidelity Platinum Taq DNA
polymerase. To prepare the CES1A1-3582m-Luc reporter, site-directed mutagenesis was
performed as described previously [16]. Complementary oligonucleotides (5′-
CTCACCCATCACAATGTACTGAGGAATCATGAAGCAGAAA-3′) were synthesized to
introduce substitutions (underlined). The primers were annealed to the CES1A1-3582-Luc
reporter and subjected to a thermocycler for a total of 15 cycles. The resultant PCR-
amplified constructs were then digested with Dpn I to remove the non-mutated parent
construct. The mutated PCR-amplified constructs were used to transform XL1-Blue
bacteria. To prepare element reporters, oligonucleotides (Table I) were synthesized,
annealed and ligated into the pGL3 promoter vector through Nhe I and Xho I. All reporter
constructs were subjected to sequence analysis. To determine the reporter activities,
cotransfection in Huh7 cells (human hepatic cellular carcinoma line) was performed.
Transfection mixtures contained 100 ng of a reporter plasmid and 0.2 ng of CMV-Renilla
luciferase plasmid. In some cases, Nrf1 and Nrf2 constructs were included. Nrf1 construct
was a gift of Dr. Jefferson Y. Chan of University of California Irvine whereas Nrf2 construct
was purchased from OriGene (Rockville, MD). The corresponding vector was used to
equalize the total amount of plasmid DNA. Typically, cells were transfected for 12 h and the
medium was replaced with fresh medium supplemented with 1% FBS. The treatment lasted
for 24 h and the cells were washed once with phosphate buffered saline and collected by
scraping. The reporter enzyme activities were assayed with a Dual-Luciferase Reporter
Assay System as described previously [16].
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2.3. Electrophoretic mobility shift assay (EMSA)
The EMSA experiment was performed as described previously [17]. Nuclear extracts of
Huh7 cells treated with SFN (10 μM) for 24 h were prepared with the nuclear and
cytoplasmic extraction kit (Pierce, Rockford, IL). The sense and antisense oligonucleotides
(Table I) were annealed by heating at 94°C for 5 min followed by gradually cooling to room
temperature. The sense strand was synthesized as labeled or non-labeled form (for
competition). Nuclear protein (5 μg) was incubated with a double-stranded biotinylated
probe (0.1 pmol) at room temperature for 20 min. In competition assays, nuclear extracts
were first incubated with an unlabeled probe at a 25× or 100× excess for 5 min before
addition of the labeled probe. For antibody-disruption assay, the nuclear extracts were first
incubated with an antibody against Nrf2 (C-20) on ice for 20 min and then with the labeled
probe. The protein-DNA complexes were resolved by nondenaturing polyacrylamide gel
electrophoresis (5%) and transferred onto a Biodyne® nylon membrane. The biotinylated
probe was detected with streptavidin-conjugated horseradish peroxidase and
chemiluminescent substrate (PIERCE, Rockford, IL). The chemiluminescent signal was
captured by KODAK Image Station 2000, and the relative intensities were quantified by
KODAK 1D Image Analysis Software (KODAK Molecular Imaging Software, Version 4.0,
Rochester, NY).
2.4. Chromatin immunoprecipitation (ChIP)
ChIP experiment was performed, essentially described previously [17]. Huh7 Cells were
treated with SFN (10 μM) for 24 h, washed and underwent cross-linking for 15 min by 1.0%
formaldehyde at room temperature, and the cross-linking was terminated with glycine (final
concentration of 125 mM). The soluble chromatins were prepared as described previously
[17]. For ChIP experiment, chromatins were pre-cleared for 2 h at 4°C with protein G beads
pre-treated with herring sperm DNA (0.2 mg/ml) and BSA (0.5 mg/ml). A fraction of the
pre-cleared chromatins was stored at −80°C for later use as an input. An antibody against
Nrf2 was added into the pre-cleared chromatins, and an overnight incubation at 4°C was
performed. As a negative control, incubation was performed with pre-immune IgG. The
antibody-bound chromatins and DNA input were analyzed by PCR for the presence of the
genomic fragments containing the Nrf2-bound element with primers shown in Table I. The
PCR was performed with Platinum Taq DNA polymerase for a total of 32 cycles at 94°C for
30 s, 58°C for 30 s and 68°C for 60 s. A 3-min initial denaturation was performed.
2.5. Non-reducing polyacrylamide gel electrophoresis coupled Western blotting
Non-reducing polyacrylamide gel electrophoresis was performed, essentially as described
previously [18]. Briefly, 293T cells (human embryonic kidney expressing the simian virus
40 large T antigen) at 85% confluence in 24-well plates were transfected with Flag-tagged
mouse or human keap1 (250 ng/well). The Flag tagged Keap1 constructs were kindly
provided by Dr. Anil K. Jaiswail of the University of Maryland [12]. After a 24 h-
incubation, the transfected cells were washed and then treated for 1 h with SFN or TNBS at
various concentrations. The treated cells were extensively with PBS containing 40 mM N-
ethylmaleimide (NEM) and the lysed in NEM-containing RIPA buffer. Lysates (4 μg) were
mixed with an equal volume of denaturing sample buffer without reducing agent (62.5 mM
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Tris–HCl, pH 6.8, containing 10.8% glycerol, 0.001% bromophenol blue, and 1% SDS), and
heated at 95 °C for 5 min. Samples were subjected to SDS–PAGE under non-reducing
conditions [18] and subsequently transferred electrophoretically to an Immobilon-P
membrane (Millipore, Bedford, MA). After non-specific binding sites were blocked with 5%
non-fat milk, the blots were incubated with an anti-Flag antibody as described previously
[16]. This experiment was repeated four times and consistent results were obtained.
2.6. Other analyses
Protein concentrations were determined with BCA assay (Pierce) based on albumin
standard. Western analysis and the preparation of anti-CES1 antibody were described
elsewhere [18-20]. RT-qPCR with Taqman probes was performed as described previously
[21]. The Taqman probe identification numbers were: Hs00275607_m1 for CES1,
Hs00168547_m1 for NAD(P)H:quinine oxidoreductase 1 (NQO1), 4352934E for GAPDH
and Hs00172187_m1 for RNA polymerase II. Data are presented as mean ± SD of at least
three separate experiments, except where results of blots are shown in which case a
representative experiment is depicted in the figures. All data were analyzed for statistical
significance with PASW Statistics 18. Significant differences were made according to One-
way ANOVA followed by a DUNCAN's multiple comparison test (p < 0.05). Bars assigned
different letters indicate statistical significance among data-points.
3. Results
3.1. CES1 induction by SFN and TNBS in primary cultures and cell lines
Humans are exposed to antioxidants and sensitizers primarily through the gastrointestinal
track and skin. We first confirmed whether induction of CES1 by SFN and TNBS occurs
comparably in primary cultures and cell lines (Huh7 and human fibrosarcoma cell line
HT1080) from these organs. Cells were treated with SFN or TNBS and CES1 expression
was determined initially by RT-qPCR with a Taqman probe. This probe recognizes both
CES1A1 and CES1A2 mRNA. In addition, the mRNA level of NAD(P)H:quinone
oxidoreductase (NQO1), an Nrf2 target gene [22], was determined as well. As summarized
in Fig. 1, both SFN and TNBS significantly increased CES1 and NQO1 mRNA. The highest
induction of CES1 mRNA was 3.9-fold and occurred in Huh7 cells treated with SFN (Fig.
1D) and the least (1.6 fold) in primary hepatocytes treated with TNBS (Fig. 1C). In contrast,
the highest induction of NQO1 mRNA was 5.7-fold and occurred in primary hepatocytes
(Fig. 1C), the least (1.9-fold) in primary fibroblasts treated with SFN (Fig. 1A). Except for
HT1080 cells, SFN caused greater induction of CES1 than TNBS, and NQO1 mRNA was
induced to a greater or comparable extent by TNBS (Fig. 1). In HT1080 cells, TNBS caused
slightly higher induction of CES1 mRNA than SFN but the opposite was true on NQO1
induction (Fig. 1B). Both SFN and TNBS markedly increased CES1 protein (Fig. 1E).
3.2. Stimulation of the CES1A1 promoter by SFN, TNBS and Nrf2
Nrf2 was implicated in the induction of CES1A1 by antioxidants including SFN [14], and
many sensitizers are potent activators of Nrf2 [13]. We next tested whether TNBS and SFN
induce CES1A1 via the same Nrf2 element. Reporters were prepared to contain the CES1A1
promoter and upstream sequence at varying length. As shown in Fig. 2A, reporters
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containing upstream sequence of 3582 bp (i.e., -3582) or further responded to both SFN and
TNBS. The CES1A1-3582-Luc reporter was activated the most (Fig. 2A). In contrast, the
other reporters, containing shorter sequence than the CES1A1-3582-Luc reporter, were
suppressed by both chemicals, and the suppression was greater on CES1A1-3432-Luc and
CES1A1-2293-Luc than CES1A1-1426-Luc (Fig. 2A).
Next we tested whether these reporters show a similar pattern of response to Nrf2. Huh7
cells were transfected with a reporter, along with Nrf2 or the vector. Consistent with the
results on the TNBS and SFN treatment, the sequence from -3582 to -3432 was identified to
support Nrf2-transactivation (Fig. 2B). Likewise, the CES1A1-3432-Luc and
CES1A1-2293-Luc reporters were repressed by Nrf2 (Fig. 2B). To further narrow down the
sequence supporting the action of Nrf2, deletions of the CES1A1-3582-Luc reporter were
made from the 5′ end and the resultant reporters were tested for the lost responsiveness to
Nrf2. As shown in Fig. 2C, the reporter 1A1-3492-Luc but not 1A1-3482-Luc was
transactivated by Nrf2. Actually, the 1A1-3482-Luc reporter was repressed by Nrf2. These
findings suggest that the 10-base sequence from -3492 to -3482 was critical for Nrf2-
transactivation.
3.3. Characterization of the S/ARE element
The study with deletion mutants suggested that this 10-base sequence contains or is part of
the Nrf2/TNBS/SFN response element: designated the S/ARE element. We next performed
a set of experiments to characterize this element. We first tested whether Nrf2 binds S/ARE
element and whether this binding can be competed by ARE4 (-2031), an element previously
identified to support Nrf2-transactivation [14]. As shown in Fig. 3A, incubation of a biotin-
labeled S/ARE probe with nuclear extracts from SFN-treated cells produced a shifted band
(lane 2). This band was eliminated by an Nrf2 antibody (lane 3) and competed by non-
labeled S/ARE (lanes 4 and 5), but not its mutant (lanes 6 and 7). In addition, non-labeled
ARE4 element effectively competed the binding as well (lanes 8 and 9). Nevertheless, this
experiment demonstrated that both the S/ARE and ARE4 were bound by Nrf2. We next
tested whether the S/ARE-containing sequence is intracellularly occupied by Nrf2. ChIP
analysis was performed with an Nrf2 antibody and the precipitated DNA was detected for
the enriched S/ARE- or ARE4-fragment. As shown in Fig. 3B, comparable amplifications
were detected with the input on both S/ARE-and ARE4-fragments, however, the ChIPed
DNA produced robust amplification of the S/ARE-but not ARE4-fragment (Fig. 3B). As
expected, no amplification was detected with sample precipitated with pre-immune IgG.
3.4. Activation of the S/ARE element reporter by SFN, TNBS and Nrf2
The EMSA and ChIP experiments demonstrated that the S/ARE element serves as a major
site for Nrf2 to interact with the CES1A1 gene. We next tested whether the interaction
confers biological activities. Three reporters were tested including the S/ARE,
CES1A1-3582-Luc and CES1A1-3582m-Luc reporters (Fig. 4A). The CES1A1-3582m-
Luc, a mutant of the CES1A1-3582-Luc, had the S/ARE element replaced with its mutant
sequence (Table I). Cotransfection was performed to test the responsiveness of these
reporters to SFN, TNBS and Nrf2. As shown in Fig. 4B, SFN at 0.5 μM significantly
activated the S/ARE reporter and the CES1A1-3582-Luc (bars labeled with different letters).
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Higher concentrations caused higher activation of both reporters except 10 μM on the
S/ARE reporter (Fig. 4B). In contrast, none of the concentrations activated the
CES1A1-3582m-Luc reporter. Similar responding patterns to TNBS were detected (Fig.
4C). Likewise, Nrf2 increased the activities of S/ARE and CES1A1-3582-Luc but not
CES1A1-3582m-Luc reporter (Fig. 4D). Nonetheless, it was surprising that higher amounts
of Nrf2 (10 and 20 ng) significantly repressed the mutant reporter CES1A1-3582m-Luc
(Fig. 4D).
3. 5. Activation comparison of S/ARE element with other Nrf2 elements
The EMSA, ChIP and reporter experiments established that the S/ARE element supported
robust responsiveness to SFN, TNBS and Nrf2. Next, we compared the responding potential
of this element with well-characterized Nrf2 elements. Reporters harboring the CES1A1-
ARE4 element or the corresponding CES1A2-S/ARE were also included. In addition to
Nrf2, these reporters were tested for their responsiveness to Nrf1, an Nrf2 functionally
related protein [23]. For direct comparison, reporters were prepared to contain a single copy
of an ARE element. As shown in Fig. 5, all reporters were transactivated by Nrf1 and Nrf2
except Nrf1 on the NQO1 reporter (Fig. 5A) and Nrf2 on the 1A1-ARE4 reporter (Fig. 5A).
In both cases, their activity was actually decreased, and the decrease was statistically
significant in the 1A1-ARE4 reporter (Fig. 5A). With a single exception (i.e., 1A1-ARE4),
Nrf2 caused greater activation than Nrf1 on all reporters tested. The highest transactivation
was detected with the CES1A1-S/ARE reporter (5.8 fold) followed by the CES1A2-S/ARE
reporter (5.2 fold). The CES1A2-S/ARE reporter (Fig. 5A), compared with its CES1A2-
S/ARE counterpart, was activated to a greater extent by Nrf1. In some other cases such as
the reporter of GCLM (glutamate-cysteine ligase regulatory subunit), Nrf1 and Nrf2 caused
comparable activation (Fig. 5A).
3.6. Differential reactivity of SFN and TNBS toward Keap1
We have shown that the S/ARE element was critical for the transactivation of CES1 by Nrf2
in response to SFN and TNBS. It is well established that Nrf2 transactivation is trigged by
dissociating from Keap1 [12]. In the Keap1-Nrf2 pathway, Keap1 is the initiator whereas
Nrf2 is the executor [12]. Keap1 is a cysteine-rich protein and some of the cysteines serve as
reactive targets for antioxidants and sensitizers. As a result, Keap1 has three forms
depending on the oxidative status of cysteines: reduced Keap1, intramolecular and
intermolecular Keap1. We took advantage of their differences in electrophoretic mobility
and tested whether SFN and TNBS produce similar composition of these three Keap1
molecular species. Cells were transfected with Keap1 and treated with SFN or TNBS at
various concentrations and the cell lysates were then separated by non-reducing
electrophoresis followed by Western blotting. As shown in Fig. 6, both SFN and TNBS
decreased reduced mouse Keap1. Surprisingly they differed in increasing intramolecular and
intermolecular Keap1. SFN increased intramolecular Keap1 whereas TNBS increased
intermolecular Keap1. Similar changes were detected with human Keap1, although to a
much less extent (Fig. 6).
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4. Discussion
CES1 is the most versatile human carboxylesterase and catalyzes hydrolysis, synthesis and
transesterification [1, 2]. In this study, we reports that TNBS and SFN efficaciously induced
CES1 through Nrf2 via two elements: S/ARE and ARE4. Nrf2 binds to both elements (Fig.
3A), although they exhibited opposite activities (Fig. 5A). S/ARE supported transactivation
whereas ARE4 supported repression of Nrf2, although S/ARE was a more sensitive target
(Figs. 4D and 5A). Actually, the S/ARE reporter was activated the most by Nrf2 among all
ARE reporters (Fig. 5). Compared with all AREs, ARE4 differs by two nucleotides at the 4th
and 5th position in the core-sequence (Fig. 5B). The ARE4 has GA whereas other AREs
have CT in these positions. However, a frequency matrix analysis has predicted that 18% of
ARE elements have a G and 6% an A in the 4th and 5th position, respectively [24],
suggesting that this dinucleotide substitution (i.e., CT→GA) may not be entirely responsible
for the observed repression by Nrf2 (Fig. 5B).
It is likely that this GA→CT substitution works with flanking nucleotides and negatively
responds to Nrf2. Indeed, computer program ALGGEN-PROMO predicts that the ARE4
core-sequence overlaps with a Yin-Yang1 (YY1) element. This element, CGTGAGACA,
consists of 5′ flanking dinucleotide CG and seven nucleotides of the ARE4 core sequence
(in italic) including the dinucleotide GA discussed above (Fig. 6). Importantly, a recent
study has shown that Nrf2 negatively regulated the transcription of the fibrosis
transmembrane conductance receptor gene (CFTR) through an YY1 element overlapped
with an ARE (CAAATGACA underlined) [19-25]. Although the CES1A1 YY1 element
shares five nucleotides with the CFTR YY1 element, the CES1A1 YY1 element lacks the
typical core nucleotides of YY1 element [19]. However, these authors detected YY1-Nrf2
complex [25], suggesting that YY1 and Nrf2 form heterodimers and bind to an YY1-Nrf2
composite site. On the other hand, Nrf2 has been established to preferably form
heterodimers with small Maf proteins and confer transactivation activity [26, 27], thus
dominating the repression through the YY1-Nrf2 mechanism [Fig. 6]. In support of this
notion, the repression of CES1A1 reporters was evident when Nrf2 was highly expressed
(Fig. 2A), or in the absence of the S/ARE element (Figs. 3D and 5B). Nevertheless, a
confirmation of YY1, along with Nrf2, in the suppression of CES1 will provide an example
of how a very same gene can be regulated by the same transcription factor with opposite
regulatory activity.
Another interesting finding is that SFN and TNBS caused different changes in the overall
conformation of Keap1. SFN promoted thiol oxidation of Keap1 within Keap1, whereas
TNBS promoted the thiol oxidation between two Keap1 molecules (Fig. 5). Thus, TNBS
induced the formation of large Keap1 complex. The precise mechanism on the difference
remains to be determined. It is likely that TNBS activates the Keap1-Nrf2 pathway by
directly reacting sulfhydryl groups of Keap1, whereas SFN activates it by altering the
cellular oxidative potentials. In support of this possibility, TNBS but not SFN is potent
sulfhydryl agent [28, 29]. However, it remains to be determined whether the different
reactivity between SFN and TNBS represents general difference between antioxidants and
skin sensitizers. Nevertheless, majority of skin sensitizers are sulfhydryl reactive agents [10,
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13]. It should be emphasized that the effect on oxidative status of Keap 1 was more
profound with mouse than human Keap1 (Fig. 6).
Carboxylesterases are generally considered detoxification enzymes, therefore, induction of
CES1 likely represents cytoprotective response [1, 5]. On the other hand, induction of CES1
may have pharmacological significance, particularly regarding the metabolism of ester
drugs. For example, the antiplatelet agent clopidogrel is activated by oxidation (5%) but
inactivated by hydrolysis (95%) [2]. As a result, exposure to antioxidants or skin sensitizers
may decrease the antiplatelet activity of clopidogrel. In contrast, hydrolysis of oseltamivir, a
widely used anti-influenza agent, represents activation, and only the hydrolytic metabolite
exerts anti-influenza activity [30]. Therefore, induction of CES1 likely leads to increased
anti-viral activity of oseltamivir. We have shown that the hydrolytic metabolite, compared
with the parent compound oseltamivir, is more cytotoxic [30]. However, the Nrf2-mediated
induction of CES1 may cause little changes in the overall toxicity as this pathway has also
been found to support the induction of multidrug resistance protein-4 [31], a transporter that
effluxes the hydrolytic metabolite [32].
In addition to the pharmacological implications, induction of CES1 may have
pathophysiological significance as well. CES1 hydrolyzes many endogenous compounds
such as triglycerides and cholesterol esters [1, 4, 5]. Hydrolysis of cholesterol esters
increases free cholesterol, leading to increased synthesis of bile acids [4]. Secretion of bile
acids represents the only net elimination of excessive cholesterol [33]. On the other hand,
increased free fatty acids by hydrolyzing triglycerides and cholesterol esters likely increase
the synthesis and secretion of very low density lipoprotein (VLDL), a precursor that leads to
the formation of low density lipoprotein (LDL) [34-36]. Indeed, high CES1 activity has been
shown to facilitate VLDL maturation [35]. Transgenic expression of CES1 leads to
increased secretion of apoB proteins and plasma triglycerides [34]. Elevated level of LDL
increases the risk of developing atherosclerosis [37]. Therefore, excessive induction of
CES1 without enhancing bile acid synthesis likely has detrimental effect.
Our study points to several important conclusions. (1) both SFN and TNBS are potent
inducers of CES1 in various types of cells, establishing that induction of CES1 by
antioxidants and sensitizers represents a general phenomenon; (2) the induction is achieved
by transactivation through the same response element, further establishing that Nrf2 is a
master sensor for functionally diverse compounds; (3) the S/ARE element, differing by a
single nucleotide compared with Nrf2 consensus sequence, but is transactivated the most by
Nrf2 among all element reporters tested, establishing that the consensus sequence does not
represent the optimum for Nrf2 transactivation; (4) SFN and TNBS differ in inducing
conformational changes of Keap1, establishing that compounds, although triggering the
dissociation of Nrf2 from Keap1, use different recognition. Finally, the ARE4 element
supports Nrf2 repression, establishing that flanking sequence, probably with an involvement
of the native promoter, rather than the element itself specifies the nature of regulatory
activities of Nrf2. Interestingly, Nrf1, commonly sharing the activity with Nrf2, surprisingly
activates ARE4, providing an example of function-sharing proteins with opposite regulatory
activity toward a target gene. High levels of CES1 are linked to lipid retention [7-9].
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Excessive induction of CES1 by antioxidants and sensitizers may provide a mechanism for
potential detrimental effect on human health [41].
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Abbreviations
AKR1C2 aldo-keto reductase-1C2
ARE antioxidant response element
CES carboxylesterase
ChIP chromatin-immunoprecipitation
CYP cytochrome P450
DMEM Dulbecco's Modified Eagles Medium
EMSA electrophoretic mobility shift assay
FBS fetal bovine serum
GAPDH glyceradehyde-3-phosphate dehydrogenase
GCLC glutamate-cysteine ligase catalytic subunit
GCLM glutamate-cysteine ligase regulatory subunit
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NQO1 NAD(P)H:quinone oxidoreductase
Nrf2 Nuclear factor-E 2 related factor-2
PBS phosphate buffered saline
RT-qPCR reverse transcription-quantitative polymerase chain reaction
S/ARE sensitizing/antioxidant response element
SFN sulforaphane
TNBS trinitrobenzene sulfonate
WME William's medium E
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Fig. 1. Induction of CES1 by SFN and TNBS
Cells were cultured in 12-well plates and were treated with SFN (10 μM), TNBS (10 μg/ml)
or DMSO for 24 h. Total RNA was isolated and subjected to qRT-PCR analysis for the level
of CES1 mRNA (A-D) by Taqman probes as described in the section of Materials and
Methods. The signals from each target were normalized based on the signal from GAPDH
and polymerase II and expressed as mean ± SD. Four individual donors were tested on
human dermal fibroblasts, five on human hepatocytes and three separate experiments were
performed on cell lines. The asterisk signs indicate statistical significance (P < 0.05) from
DMSO-treated cells. To determine the corresponding induction at the protein level, lysates
(20 μg) from control and treated Huh7 cells were subjected to SDS-PAGE and transferred
electrophoretically to Trans-Blot nitrocellulose membranes. The immunoblots were blocked
in 5% non-fat dry milk, incubated with the antibody against CES1 or GAPDH. The blots
were detected with chemiluminescent substrate (E).
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Fig. 2. Identification of sensitizing/antioxidant response element
(A) Activation of CES1A1 reporters by SFN or TNBS Huh7 cells in 48 well-plates were
transiently transfected by GenJet version II. For the SFN and TNBS treatment experiment,
the transfection mixture contained 50 ng of a reporter and 0.2 ng of the CMV-Renilla
luciferase plasmid. After incubation at 37°C for 12 h, the transfected cells were treated with
SFN (10 μM), TNBS (10 μg/ml) or the same volume of DMSO for 24 h. Luciferase
activities were determined with a Dual-Luciferase Reporter Assay System and the reporter
activity was expressed as fold of activation. For the Nrf2 experiment, the transfection
mixture contained 50 ng of a reporter and 0.2 ng of the CMV-Renilla luciferase plasmid,
along with 10 ng Nrf2 expression construct or the corresponding vector. (B) Activation of
CES1A1 reporters by Nrf2 Transfection was performed as described above but the the
transfection mixture contained 10 ng Nrf2 expression construct or the corresponding vector.
(C) Identification of CES1A1 Nrf2 response element To further narrow down the sequence
that supports the responsiveness to Nrf2, the CES1A1-3582-Luc was further shortened from
the 5′ end by 20 or 10 bases, and cotransfection was then performed as described above.
Data were collected from three independent experiments.
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Fig. 3. Analyses of the S/ARE element by EMSA and ChIP
(A) EMSA analysis Nuclear extracts (5 μg) from Huh7 cells treated with SFN (10 μM) were
incubated with a biotinylated probe containing the S/ARE element (0.1 pmol) for 20 min. In
the competition assay, nuclear extracts were pre-incubated with the unlabeled S/ARE
element, S/ARE mutant or ARE4 at 25× or 100× excess for 5 min, and then incubated with
the biotinylated probe. In disruption assay, nuclear extracts were incubated first with an
antibody against Nrf2 on ice for 20 min and then with the biotinylated probe. The protein-
DNA complexes were electrophoretically resolved and transferred to a Biodyne® nylon
membrane. The biotinylated probe was located with streptavidin-conjugated horseradish
peroxidase and chemiluminescent substrate. (B) ChIP analysis Huh7 Cells were treated with
SFN (10 μM) for 24 h, washed and underwent cross-linking for 15 min by 1%
formaldehyde, and the cross-linking was terminated with 125 mM glycine. The soluble
chromatins were prepared, pre-cleared with protein G beads and incubated with anti-Nrf2
antibody or pre-immune IgG. The antibody-bound chromatins and DNA input (1/20 of the
antibody-bound chromatins) were analyzed by PCR for the presence of the genomic
fragments containing the Nrf2-bound element with the primers indicated in the diagram. The
primer sequences are shown in Table I.
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Fig. 4. Functional characterization of the S/ARE element
(A) Activation of S/ARE containing or disrupting reporter by SFN Huh7 cells were
transiently transfected by a reporter (50 ng) of the S/ARE-Luc, CEA1A1-3582-Luc or its
mutant CES1A1-3582m-Luc along with 0.2 ng of the CMV-Renilla luciferase plasmid.
After incubation at 37°C for 12 h, the transfected cells were treated with SFN (0-10 μM) or
the same volume of DMSO for 24 h. Luciferase activities were determined and the reporter
activity was expressed as fold of activation. (B) Activation of S/ARE containing or
disrupting reporter by TNBS Huh7 cells were transiently transfected as described above but
treated with TNBS (0-10 μg/ml). Likewise, the reporter activities were determined. (B)
Activation of S/ARE containing or disrupting reporter by Nrf2 Huh7 cells were transiently
transfected with 50 ng reporter and 0.2 ng of the CMV-Renilla luciferase plasmid along with
0-20 ng Nrf2 expression construct. The corresponding vector was used to equalize the
amount of total plasmid. The luciferase activities were determined 24 after the transfection.
Asterisk and pound signs indicate statistical significance from the controls or between two
data points linked by a line (P < 0.05).
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Fig. 5. Differential activation of various ARE reporters by Nrf1 and Nrf2
Huh7 cells were transiently transfected by a reporter (50 ng) and the CMV-Renilla luciferase
plasmid (0.2 ng) along with 10 ng Nrf1, Nrf2 or the vector. The luciferase activities were
determined 24 h after the transfection. The core-Nrf2 sequence from known Nrf2 target
genes is shown in B. Asterisk and pound signs indicate statistical significance from the
controls or between two data points linked by a line (P < 0.05).
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Fig. 6. Interaction of SFN and TNBS with kKap1
Cells (293T) at 85% confluence in 24-well plates were transfected with Flag-tagged mouse
or human keap1 (250 ng/well). After a 24 h-incubation, the transfected cells were washed
and then treated for 1 h with SFN or TNBS at various concentrations. Thereafter, cells were
extensively with PBS containing 40 mM Nethylmaleimide (NEM) and the lysed in NEM-
containing RIPA buffer. Lysates (4 μg) were analyzed by Western blotting with an anti-Flag
antibody. This experiments were repeated four times and consistent results were obtained.
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Fig. 7. Diagrammatical presentation of regulated transcription of the CES1A1 through the
S/ARE and ARE4 elements
The width of the arrows between Nrf2 to small Maf and Nrf2 to YY1 suggests the
dominance of the formation of Nrf2-Maf dimmers over that of Nrf2-YY1 dimers. The
double ended arrow between the Nrf2-YY1 dimers and the YY1-Nrf2 composite element
suggests weak interaction. The dotted lines indicate possible direct interactions.
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Table I
Sequences of Oligonucleotides
Oligonucleotide Sequence
Native promoter reporters
CES1A1-6560-MluI 5′-CTGCAACCTTCCCATCTCAGCTGTGACCCA-3′
CES1A1-6448-MluI 5′-AGCTAATGAATAGGATCTGGGTTTATAATC-3′
CES1A1-5017-MluI 5′-CAATACCCTAATTTCGATCTCTGAATGACC-3′
CES1A1-3582-MluI 5′-TATTGCTTACAGCTGAAGTG-3′
CES1A1-3432-MluI 5′-CAGGCAAAACCTAGGAGTGG-3′
CES1A1-2293-MluI 5′-TGATTAGAATATCTTCCTGATGTATAAAAG-3′
CES1A1-1426-MluI 5′-GATGTTTTCCAGCTTCATCCACGTTGTAGC-3′
CES1A1-3552-MluI 5′-GTTATATGTATTAAGCAAAA-3′
CES1A1-3532-MluI 5′-TTAGATCTATTGTAAGGCT-3′
CES1A1-3512-MluI 5′-TGGTAGGCTCCAGCCTCACC-3′
CES1A1-3492-MluI 5′-CATCACAATCTGCAGAGTCA-3′
CES1A1-3482-MluI 5′-TGCAGAGTCATCATGAAGCA-3′
CES1A1-10484XhoI 5′-ATACACTCGAGTCGGGGCCTGCGAGGTCTCTGTGCA-GTTCA-3′
Element reporters
CES1A1-S/ARE 5′-CACAATCTGCAGAGTCATCATGAAG-3′
CES1A1-ARE4 5′-TTAAGATCGTGAGACAGCATTAATC-3′
CES1A2-S/ARE 5′-CACAATCTGCAGAATCATCATGAAC-3′
AKR1C2-ARE 5′-TTGATGCAGTCAGGGTGACTCAGCAGCT-3
GCLM-ARE 5′-GAAGACAATGACTAAGCAGAAATC-3′
GCLC-ARE 5′-CCTCCCCGTGACTCAGCGCTTTGT-3′
NQO1-ARE 5′-AGTCACAGTGACTCAGCAGAATCT-3′
EMSA
CES1A1-S/ARE 5′-CACAATCTGCAGAGTCATCATGAAG-3′
CES1A1-S/ARE(mutant) 5′-CACAATGTACTGAGGAATCATGAAG-3′
CES1A1-ARE4 5′-TTAAGATCGTGAGACAGCATTAATC-3′
ChIP
P1 5′- TATTGCTAGCCTGAAGTGTTGCAGGGGAGTT-3′
P2 5′- ACACCTCGAGCTGGCTCTTGGCCTATGAAGA-3′
P3 5′- ATAAGCTAGCTGAGTTGAGCCTATGTATTAG-3′
P4 5′- CATTCTCGAGTCCTGGCTGTAATCTTGTCAG-3′
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